Sandoz, a global leader in generic pharmaceuticals and a subsidiary of Novartis, has received approval from the US Food and Drug Administration (FDA) for Glatopa. Glatopa is the first FDA-approved, substitutable generic version of Copaxone® 20mg, a treatment for relapsing forms of multiple sclerosis. Sandoz, together with Momenta, is proud to be the first company to receive FDA approval for a substitutable generic version of this important therapy.
Bacteria can use tiny magnetic particles to effectively create a 'natural battery', a new study has found. The bacteria can load electrons onto and discharge electrons from microscopic particles of magnetite, researchers said. This discovery holds out the potential of using this mechanism to help clean up environmental pollution, and other bioengineering applications, they said.
A new study from the Forsyth Institute is helping to shed more light on the important connection between the mouth and heart. According to research recently published online by the American Heart Association, scientists at Forsyth and Boston University have demonstrated that using an oral topical remedy to reduce inflammation associated with periodontitis, more commonly known as gum disease, also results in the prevention of vascular inflammation and can lower the risk of heart attack.
Genetically modified Salmonella can kill cancer cells, suggests new research published in mBio, an American Society for Microbiology. one particular strain of salmonella found to be most effective at killing cancer cells and shrinking tumors, and also not toxic.
Results from the phase 1 clinical trial of an Ebola vaccine based on the current strain of the virus suggests it is safe to use and provokes an immune response in recipients, Chinese scientists say. Until now, all tested Ebola virus vaccines have been based on the virus strain from the Zaire outbreak in 1976.
In a world first, researchers have found that a naturally occurring chemical attracts pregnant malaria transmitting mosquitoes - a discovery which could boost malaria control efforts. The chemical, cedrol, found in mosquito breeding sites near Africa's Lake Victoria, could be used in traps that would 'attract and kill' the female mosquito, preventing reproduction before she lays hundreds of eggs.
Australian researchers have developed a new genome editing technology that can target and kill blood cancer cells with high accuracy. Using the technology, researchers from the Walter and Eliza Hall Institute were able to kill human lymphoma cells by locating and deleting an essential gene for cancer cell survival.
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
